1. Scope
1.1 This test method covers the determination of the degree of deacetylation in chitosan
and chitosan salts intended for use in biomedical and pharmaceutical applications
as well as in Tissue Engineered Medical Products (TEMPs) by high-resolution proton
NMR (1H NMR). A guide for the characterization of chitosan salts has been published as Guide
F2103.